November 18, 2020  • Virtual Conference

November 18, 2020 • Virtual Conference

IBD Innovate

Registration coming soon!

Conference Overview

  • Presentations on compelling inflammatory bowel disease (IBD) product opportunities in:
    • Therapeutics (from compound discovery through clinical development)
    • Devices
    • Diagnostics
    • Healthcare technology (software, services etc.)
  • Networking & connections between diverse stakeholders in the IBD space
  • Intended for startups, commercial-stage companies, academics, funders, clinicians, patient advocates, etc.

The Crohn's & Colitis Foundation seeks to accelerate the discovery and development of novel products with the potential to address the unmet needs of patients with IBD. In pursuit of this objective, the Foundation recently launched IBD Ventures to directly fund product discovery and development.

Building on the launch of IBD Ventures, this third annual conference, IBD INNOVATE: Product Development for Crohn’s & Colitis, will showcase innovative product development programs in IBD. This event will be an exceptional networking opportunity for all stakeholders dedicated to advancing innovative products to address the critical challenges faced by IBD patients. 

Our 2020 event will take place on a virtual conference platform and will include a wide variety of networking options (including 1:1 partnering, matchmaking resources, "speed dating" breakout sessions and more), a customizable virtual conference experience, and an expanded guest list featuring increased international participation!

Browse past programs:

Target audience:

Startup companies, accelerator organizations (industry, non-profit & academic), industry representatives (R&D, clinical development, external R&D, scouting, partnering, business development, corporate venture), academic researchers, investors (venture capital & other), disease foundations and other non-profit funders, contract research organizations, service providers, clinicians, and patient advocates.


Check back soon for our 2020 agenda!


Our 2020 speakers will address a wide variety of topics: Ramnik Xavier (Massachusetts General Hospital and the Broad Institute) will present a keynote address on novel therapeutics discovery based on emerging concepts in IBD biology. Additional confirmed speakers will discuss small molecule therapeutics (Susan Schwab, NYU and Barbara Slusher, Johns Hopkins), large molecule therapeutics (John Mumm, Deka Biosciences), microbiome targeted therapeutics (Paul Miller, Artizan Biosciences), live bacterial therapeutics (Rose Szabady, Vedanta Biosciences), cell therapy (Amy Lightner, Cleveland Clinic), medical devices (Chris Puleo, GE Research and Gil Melmed, Cedars Sinai), diagnostics (Christian Fermer, Fujirebio) and healthcare technology / digital health (Jen Horonjeff, Savvy Cooperative). More speakers to be announced soon.

Networking resources:

1:1 partnering software to facilitate networking and meeting scheduling between attendees; Foundation staff will provide additional guidance for informal and structured networking on the day of the event.


IBD Innovate is generously supported, in part, by: